Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Calibrate Health vs Harbor

Calibrate Health
Graded #125

Lower grade

vs+2.700000000000003
Harbor
Graded #86

Higher grade

The verdict

Harbor takes it — 72/100 to 69.3/100.

Harbor grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Harbor is a physician-led telehealth platform offering compounded semaglutide (from $99/mo) and compounded tirzepatide (from $149/mo) — among the lowest headline prices in the market.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHarbor +29
45
74
Dose & formulationHarbor +11
53
64
Clinical oversightCalibrate Health +5
94
89
Labs & monitoringCalibrate Health +25
88
63
FulfillmentCalibrate Health +11
92
81
Contract termsCalibrate Health +8
55
47
Calibrate Health · left barHarbor · right bar

The numbers

MetricCalibrate HealthHarbor
WeighScore69.3/10072/100
GradeCC
Scorecard rank#125#86
SemaglutideNot disclosed$99/mo (starting dose, compounded)
TirzepatideNot disclosed$149/mo (starting dose, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Calibrate Health

Graded #125 · C

Strengths

  • Year-long program with 1:1 video coaching, dietitian support, and behavior-change curriculum — a deeper clinical wrap than transactional telehealth
  • $199/month program fee is competitive; medication co-pay can drop to ~$25/month with insurance and a manufacturer savings card
  • Branded GLP-1s only (Wegovy, Ozempic, Zepbound, Foundayo) — no compounded products
  • Insurance navigation team works to maximize coverage and reportedly accepts most major commercial plans
  • Money-back guarantee tied to a 10% weight-loss outcome over the program year

Where it loses points

  • Medication cost is on top of the $199/month fee; cash-pay patients face full manufacturer pricing
  • Insurance navigation only helps if your plan actually covers branded GLP-1s for weight loss — many don't
  • Meaningfully more expensive than compounded telehealth if your insurance denies coverage
  • Distinct from 'Oxford's Medical Weight Loss (The Calibrate Clinic)' — don't confuse the two
  • Initial 3-month commitment required ($597 total, billed as $199/mo) before it renews month-to-month — more lock-in than month-to-month rivals
Harbor

Graded #86 · C

Strengths

  • Compounded semaglutide from $99/mo and tirzepatide from $149/mo — among the lowest headline prices in the market
  • LegitScript certified with 4.7-star rating, 94.6% success rate, and 10,000+ verified members
  • 24/7 physician access with ongoing consultations, dosage adjustments, and free discreet shipping
  • 12-Month Money Back Guarantee if you don't reach your weight-loss goal
  • HSA/FSA eligible; no hidden fees, no insurance billed

Where it loses points

  • Compounded medications are not FDA-approved; compounding pharmacy names not publicly disclosed
  • Dietitian support offered only post-program (maintenance phase), not during active treatment
  • State-specific consultation types vary; nationwide availability unconfirmed for all states
  • No labs disclosed; patient portal is a third-party platform (mdintegrations), not native
  • Newer brand; success rate and member counts are on-site claims, not third-party verified

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard